Opiant in the news
October 26, 2017 – Opiant CEO Dr. Roger Crystal discusses the Company’s role in combating addiction and the opioid crisis, a “public health emergency” as declared by President Trump.
October 6, 2017 – Opiant CEO Dr. Roger Crystal calls on Washington to partner with the pharma industry to tackle the opioid crisis.
September 27, 2017 – Opiant CEO Dr. Roger Crystal testifies before the President’s Commission on Combating Drug Addiction and the Opioid Crisis.
August 11, 2017 – Opiant CEO Dr. Roger Crystal discusses the opioid crisis being declared a national emergency by President Trump.
July 28, 2017 – Opiant Pharmaceuticals Inc. is best known today for its NARCAN® Nasal Spray used to treat opioid overdoses. But CEO Roger Crystal hopes to make overdoses a thing of the past for most addicts by developing a vaccine that can end heroin dependence.
July 27, 2017 – Opiant CEO Dr. Roger Crystal provides insight on ‘Fox & Friends’.
July 26, 2017 – Opiant CEO Dr. Roger Crystal on a new tool and efforts to battle the opioid crisis in America.
July 15, 2017 – Phil Skolnick, Opiant’s Chief Scientific Officer, speaks with radio station WTOP-DC about Opiant’s intranasal naloxone.
September 15, 2016 – Opiant CEO Dr. Roger Crystal explains to The Wall Street Journal how NARCAN® Nasal Spray has been used to fight against opioid overdoses on the front line.